Bookmark
Forward
PI3Kα targeting, nipping pancreatic cancer evolution in the bud.
EMBO molecular medicine 2021 Jul 07Sizes of these terms reflect their relevance to your search.
Thibault et al (2021) elucidate key signalling events mediating metastatic evolution in pancreatic ductal adenocarcinoma (PDAC) by demonstrating a role of PI3Kα in the regulation of macro-metastatic disease and a corresponding pro-tumoural immune response supporting disease progression. © 2021 Mayo Clinic. Published under the terms of the CC BY 4.0 license.
Citation
Glancis Luzeena Raja Arul, Martin E Fernandez-Zapico. PI3Kα targeting, nipping pancreatic cancer evolution in the bud. EMBO molecular medicine. 2021 Jul 07;13(7):e14362
Mesh Tags
PMID: 34057823
View Full Text
